Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 10 Years

Regeneron Pharmaceuticals REGN has outperformed the market over the past 10 years by 2.01% on an annualized basis producing an average annual return of 12.78%. Currently, Regeneron Pharmaceuticals has a market capitalization of $107.43 billion.

Buying $1000 In REGN: If an investor had bought $1000 of REGN stock 10 years ago, it would be worth $3,226.98 today based on a price of $975.00 for REGN at the time of writing.

Regeneron Pharmaceuticals's Performance Over Last 10 Years

Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.

This article was generated by Benzinga's automated content engine and reviewed by an editor.